Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 886 AL 900

Positive Impact of Holistic Nursing on Cognitive Impairment and Psychiatric Symptoms in Patients With Alzheimer's Disease

Yu J, Zhu L, Song Y, Shi B, Zhou X.

Actas Esp Psiquiatr. 2025 May;53(3):586-597. doi: 10.62641/aep.v53i3.1948.

From stress to Alzheimer's: A circuit-based framework for prefrontal cognitive dysfunction

Yi JH.

Neurosci Lett. 2025 Dec 10;869:138424. doi: 10.1016/j.neulet.2025.138424. Epub 2025 Oct 18.

Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases

Zavarella M, Cecchetti G, Rugarli G, Ghirelli A, Bottale I, Orlandi F, Spinelli EG, Santangelo R, Caso F, Calloni SF, Vezzulli PQ, Falini A, Magnani G, Agosta F, Filippi M.

J Neurol. 2025 Jan 24;272(2):168. doi: 10.1007/s00415-025-12910-x.

Artificial Intelligence-Assisted Hippocampal Segmentation and Its Diagnostic Value for Alzheimer's Disease: A Meta-analysis

Wu Q, Huang C, Zhang J, Zhang Z, Zhu X.

Acad Radiol. 2025 Aug;32(8):4785-4796. doi: 10.1016/j.acra.2025.04.038. Epub 2025 May 8.

Virtual reality as a complementary therapy in the rehabilitation of balance and gait disorders in patients with mild cognitive impairment and Alzheimer's disease: Systematic review

Rodríguez-Mansilla J, Chamizo-Gallego P, González-Sánchez B, Garrido-Ardila EM, Torres-Piles S, Rodríguez-Mansilla MJ, De Toro-García Á, Jiménez-Palomares M.

Clin Rehabil. 2025 Jun;39(6):728-739. doi: 10.1177/02692155251328619. Epub 2025 Apr 23.

Epigenetic Clocks and Their Prospective Application in the Complex Landscape of Aging and Alzheimer's Disease

Cerantonio A, Greco BM, Citrigno L, De Benedittis S, Qualtieri A, Maletta R, Montesanto A, Passarino G, Spadafora P, Cavalcanti F.

Genes (Basel). 2025 May 30;16(6):679. doi: 10.3390/genes16060679.

Neural mechanisms of non-pharmacological interventions in patients with mild cognitive impairment and Alzheimer's disease: An ALE meta-analysis

Wang N, Li J, Guo Y, Zhang P, You F, Wang Z, Wang Z, Hong X.

Exp Gerontol. 2025 Feb;200:112678. doi: 10.1016/j.exger.2025.112678. Epub 2025 Jan 9.

To know or to not know: The importance of assessing awareness of cognitive function in the early stages of Alzheimer's disease

Vannini P, Zamboni G.

J Alzheimers Dis. 2025 Aug;106(3):911-914. doi: 10.1177/13872877251350138. Epub 2025 Jun 16.

Grey-Matter Structure Markers of Alzheimer's Disease, Alzheimer's Conversion, Functioning and Cognition: A Meta-Analysis Across 11 Cohorts

Couvy-Duchesne B, Frouin V, Bouteloup V, Koussis N, Sidorenko J, Jiang J, Wink AM, Lorenzini L, Barkhof F, Trollor JN, Mangin JF, Sachdev PS, Brodaty H, Lupton MK, Breakspear M, Colliot O, Visscher PM, Wray NR; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing; Alzheimer's Disease Repository Without Borders Investigators; MEMENTO cohort Study Group.

Hum Brain Mapp. 2025 Feb 1;46(2):e70089. doi: 10.1002/hbm.70089.

Salience and frontoparietal network impairments across disease stages in dementia with Lewy bodies: A comparative functional MRI study with Alzheimer's disease

Gabriel V, Chabran E, Sourty M, Cretin B, Philippi N, Muller C, Anthony P, Demuynck C, Loureiro de Sousa P, Botzung A, Sanna L, Bousiges O, Blanc F.

J Alzheimers Dis. 2025 Dec;108(3):1398-1409. doi: 10.1177/13872877251386844. Epub 2025 Oct 17.

Structural and metabolic topological alterations associated with butylphthalide treatment in mild cognitive impairment: Data from a randomized, double-blind, placebo-controlled trial

Han X, Gong S, Gong J, Wang P, Li R, Chen R, Xu C, Sun W, Li S, Chen Y, Yang Y, Luan H, Wen B, Guo J, Lv S, Wei C.

Psychiatry Clin Neurosci. 2025 Jun;79(6):336-343. doi: 10.1111/pcn.13812. Epub 2025 Mar 31.

The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease

Torre M, Zanella CA, Feany MB.

Am J Pathol. 2025 Nov;195(11):2088-2101. doi: 10.1016/j.ajpath.2024.12.013. Epub 2025 Jan 23.

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease

Siemers E, Feaster T, Sethuraman G, Sundell K, Skljarevski V, Cline EN, Zhang H, Jerecic J, Honig LS, Salloway S, Sperling R, Trame MN, Dodds MG, Johnson K.

J Prev Alzheimers Dis. 2025 Jan;12(1):100005. doi: 10.1016/j.tjpad.2024.100005. Epub 2025 Jan 1.

Risk of Alzheimer's disease in Down syndrome: Insights gained by multi-omics

Qu HQ, Liu Y, Connolly JJ, Mentch FD, Kao C, Hakonarson H.

Alzheimers Dement. 2025 Apr;21(4):e14604. doi: 10.1002/alz.14604.

The Impact of Air Pollution and Obesity on Cognitive Decline and Risk of Alzheimer's Disease

Keller ZA, Eggers KM, Nixon JP, Butterick TA.

Int J Mol Sci. 2025 Dec 21;27(1):92. doi: 10.3390/ijms27010092.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias